Suchergebnisse - "Galluzzo, Marco"

PubPharm (7)

1

Myasthenia gravis associated with muscle-specific kinase antibodies in a patient treated with interleukin-17 inhibitor

enthalten in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology | 2023

von Papi, C. | Granata, G. | Galluzzo, M. | +1

CommentIn: Neurol Sci. 2023 Aug;44(8):2981-2982. - PMID 37041395

2

Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic : Risk analysis from the PSO-BIO-COVID observational study

enthalten in: Expert opinion on biological therapy | 2021

von Talamonti, M. | Galluzzo, M. | Chiricozzi, A. | +70

3

Status of a real-life cohort of patients with moderate-to-severe plaque psoriasis treated with secukinumab and considerations on the use of biological agents in the Covid-19 era

enthalten in: Expert opinion on biological therapy | 2020

von Galluzzo, M. | Tofani, L. | Bianchi, L. | +1

4

Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo

enthalten in: Cell cycle (Georgetown, Tex.) | 2020

von Campione, E. | Lanna, C. | Diluvio, L. | +12

5

Biologic therapy for acrodermatitis continua of Hallopeau : Successful treatment with secukinumab and review of the literature

enthalten in: Dermatologic therapy | 2019

von Galluzzo, M. | D'Adamio, S. | Teoli, M. | +2

6

Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis : SUPREME study

enthalten in: The British journal of dermatology | 2018

von Costanzo, A. | Bianchi, L. | Flori, M. | +53

7

Secukinumab in moderate-to-severe plaque psoriasis : a multi-center, retrospective, real-life study up to 52 weeks observation

enthalten in: Expert opinion on biological therapy | 2018

von Galluzzo, M. | Talamonti, M. | De Simone, C. | +7

1
[1]